RecruitingPhase 2 / Phase 3NCT05431088
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Sponsor: Pfizer
Kansas City, MO · +45 more sites
2 recruiting sickle cell disease studies with a site in Kansas City, MO.
All trials in Kansas City, MO · All Sickle Cell Disease trials
Sponsor: Pfizer
Kansas City, MO · +45 more sites
Sponsor: American Thrombosis and Hemostasis Network
Kansas City, MO · St Louis, MO · +74 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.